Principal Clinical Assessor, University Medical Center Groningen; Member SAWP, CBG-MEB (Dutch Medicines Evaluation Board)
Peter Mol is a principal assessor at the Dutch Medicines Evaluation Board and a member (vice chair) of EMA’s Scientific Advice Working Party. He is chair of the EMA Cross-Committee Task force on Registries. He is also an assistant professor at the University Medical Center Groningen...
Read More →
Scientific Project manager, HAS
Irena Guzina is a Pharmacist with a Master degree in Quality Control and Public Health. She has joined HAS in 2011, where she is working as Project manager at the Department for the Assessment of Medical Procedures. Moreover, Irena Guzina is also part of HAS EUnetHTA team. She is...
Read More →
Global Lead, Global Regulatory Policy, MSD, United Kingdom
Virginia (Ginny) has worked in industry and academia throughout her career, combining interests in science policy research and innovation performance within and across organizations. She recently joined MSD to lead regulatory policy efforts for innovation that will lead to better...
Read More →
Information and Access Director, Health Policy Advisor, European Organisation for Rare Diseases (EURODIS), France
François Houÿez is working at the European Organisation for Rare Diseases EURORDIS where he is Director of Treatment Information and Access, Policy Advisor. He has always been working as a patient advocate since the early 90s, first in the HIV/AIDS advocacy, and in rare diseases...
Read More →
Head RA EMEA, Bayer AG, Germany
Dr. Isabelle Stoeckert is Vice President and Head Regulatory Affairs Europe Middle East Africa at Bayer AG. With more than 20 years of experience in Regulatory Affairs she held several leading positions in a wide area of Regulatory and Scientific Affairs matters. Such as Vice President...
Read More →